Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Biologics Co.,Ltd.
  6. Financials
    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
End-of-day quote. End-of-day quote Korea Stock Exchange - 01/27
712000 KRW   -5.94%
01/25Samsung Biologics' Q4 Net Profit Slumps, Revenue Jumps
MT
01/18S.Korea stocks hit 7-week closing low ahead of LGES IPO
RE
01/18SAMSUNG BIOLOGICS : Prior Notice on Disclosure of Final Earnings
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 25 572 77328 649 44554 652 29047 109 48047 109 480-
Enterprise Value (EV)2 25 31728 82055 08447 35147 72046 955
P/E ratio 114x141x218x108x90,5x74,2x
Yield ------
Capitalization / Revenue 47,7x40,8x46,9x30,3x24,5x22,1x
EV / Revenue 47,3x41,1x47,3x30,5x24,8x22,0x
EV / EBITDA 172x131x128x69,4x58,9x49,5x
Price to Book 6,15x6,58x18,2x10,1x8,53x8,22x
Nbr of stocks (in thousands) 66 16566 16566 16566 16566 165-
Reference price (KRW) 386 500433 000826 000712 000712 000712 000
Announcement Date 01/31/201901/22/202001/26/2021---
1 KRW in Million
2 KRW in Billions
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 5367021 1651 5541 9212 131
EBITDA1 147220430683810948
Operating profit (EBIT)1 55,791,7293534654768
Operating Margin 10,4%13,1%25,1%34,4%34,0%36,0%
Pre-Tax Profit (EBT)1 303155266591685837
Net income1 224203241437521635
Net margin 41,8%28,9%20,7%28,1%27,1%29,8%
EPS2 3 3873 0673 7936 6117 8729 590
Dividend per Share ------
Announcement Date 01/31/201901/22/202001/26/2021---
1 KRW in Billions
2 KRW
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 261412451436430483
EBITDA ------
Operating profit (EBIT)1 74,3167167142142156
Operating Margin 28,5%40,4%37,1%32,5%33,1%32,4%
Pre-Tax Profit (EBT)1 81,7165197175156192
Net income1 62,4130132121119146
Net margin 23,9%31,4%29,2%27,7%27,6%30,2%
EPS2 9431 957-1 890--
Dividend per Share ------
Announcement Date 04/28/202107/27/202110/26/2021---
1 KRW in Billions
2 KRW
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -171432242610-
Net Cash position1 256----155
Leverage (Debt / EBITDA) -1,74x0,78x1,00x0,35x0,75x-0,16x
Free Cash Flow2 -311 065-161 581109 32033 982-31 200384 050
ROE (Net Profit / Equities) 5,51%4,77%8,76%10,2%9,85%11,9%
Shareholders' equity1 4 0664 2552 7524 3075 2865 321
ROA (Net Profit / Asset) 3,41%3,41%6,13%6,98%6,27%7,53%
Assets1 6 5825 9463 9336 2648 3118 422
Book Value Per Share3 62 80565 81245 26370 24883 43486 655
Cash Flow per Share3 5561533 7378 7708 62211 023
Capex1 348172138460721277
Capex / Sales 64,9%24,5%11,8%29,6%37,5%13,0%
Announcement Date 01/31/201901/22/202001/26/2021---
1 KRW in Billions
2 KRW in Million
3 KRW
Previous periodNext period
Key data
Capitalization (KRW) 47 109 480 000 000
Capitalization (USD) 39 159 023 466
Net sales (KRW) 1 164 776 870 000
Net sales (USD) 966 764 802
Number of employees 2 886
Sales / Employee (KRW) 403 595 589
Sales / Employee (USD) 334 984
Free-Float 25,0%
Free-Float capitalization (KRW) 11 769 866 232 000
Free-Float capitalization (USD) 9 783 518 476
Avg. Exchange 20 sessions (KRW) 49 207 032 000
Avg. Exchange 20 sessions (USD) 40 841 837
Average Daily Capital Traded 0%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA